# Leidos Holdings Inc. (LDOS) — Investment Thesis

**Exchange:** NYSE  
**Coverage as of:** 2026-Q2  
**Updated:** 2026-05-29  
**Tier:** Free primer (steps 1 & 3 of 19)  
**Sibling pages:** /stocks/LDOS/financials · /stocks/LDOS/memo

> This page shows the free thesis context (business model + recent catalysts).
> The full investment thesis (moat analysis, DCF, scenarios, risk register) is available
> via GET /api/v1/research/LDOS/memo ($2.00, Bearer token).

## Business Model

---
source: coverage-next-full
ticker: LDOS
step: "01"
title: Business Overview — Leidos Holdings
created: 2026-05-29
---

### Step 01 — Business Overview

#### Company Description

Leidos Holdings, Inc. is the largest US government IT and solutions contractor by revenue. The company traces its roots to SAIC (Science Applications International Corporation), from which it was spun off in 2013, and dramatically expanded through the 2016 acquisition of Lockheed Martin's Information Systems & Global Solutions (IS&GS) segment ($4.6B) and the 2021 acquisition of Dynetics ($1.65B). Today, Leidos employs approximately 47,000 people and generates over $16B in annual revenue, virtually all from the US federal government.

#### Core Business Model

Leidos is a government contractor that earns fees for providing technology-enabled services and solutions. Revenue is recognized primarily under long-term contracts (typically 3-7 years base + option periods) with US government agencies. The company operates across three reportable segments and generates revenue under cost-reimbursable, fixed-price, and time-and-materials contract structures. The business is asset-light: capital intensity is low, and the principal asset is the skilled, cleared workforce and the classified relationships they maintain.

#### Segment Structure

##### Defense Solutions (~55% of Revenue, ~$9.2B)
The largest segment supports the DoD, intelligence community, and international defense clients. Key programs include:
- **DISA SITE II** — enterprise IT services for the Defense Information Systems Agency
- **Airborne ISR programs** — Intelligence, Surveillance, Reconnaissance for classified customers
- **Cyber and Electronic Warfare** — offensive/defensive cyber, EW systems integration
- **C4ISR** — command, control, communications, computers
- **Dynetics products** — hypersonic systems, counter-UAS, space propulsion (acquired 2021)

##### Civil (~25% of Revenue, ~$4.2B)
Serves civilian federal agencies (NASA, DHS, DOE, FAA, NRC, FEMA) and selected commercial clients. Key programs include:
- **TSA Checkpoint Security** — explosives detection screening at major US airports (one of largest single programs)
- **NASA support contracts** — IT, engineering support at Kennedy Space Center and beyond
- **Department of Energy** — environmental management, nuclear security
- **FAA IT modernization** — air traffic control IT systems

##### Health (~20% of Revenue, ~$3.3B)
Serves the Department of Veterans Affairs, Defense Health Agency (DHA), and other HHS agencies. Key programs include:
- **VA Health Electronic Health Record Modernization** — EHR implementation (complex, multi-year)
- **DHA IT services** — Defense Health Agency enterprise IT
- **DHHQ** — Defense Health Headquarters support

#### Revenue Recognition & Contract Mix

| Contract Type | Approx. Mix | Characteristics |
|---------------|-------------|-----------------|
| Cost-Reimbursable | ~58% | Lower risk, lower margin (~6-7%); revenue = cost + fee |
| Fixed-Price | ~27% | Higher risk, higher margin potential (~8-12%); execution risk matters |
| Time & Materials | ~15% | Blended; labor rate × hours |

Fixed-price contracts have increased as a percentage over time, which benefits margins but increases program risk.

#### Customer Concentration

Leidos derives essentially all revenue from the US federal government. The DoD (including intelligence community) represents approximately 70% of total revenue, with civilian agencies at ~20% and health at ~10%. No single program represents more than ~5% of total revenue, providing diversification within the government customer base.

#### Employee & Clearance Base

Leidos's ~47,000 employees are among its most valuable assets. A significant proportion — estimated 60%+ — hold US government security clearances, many at the Top Secret/SCI level. This represents a significant switching-cost moat: cleared employees cannot be easily replaced, and clearances take 12-24 months to obtain for new hires.

#### Strategic Positioning

Leidos is positioned at the intersection of national security IT, digital transformation, and advanced technology. The company's strategic priorities under CEO Tom Bell (since January 2023) include:
1. **ODIN platform** — proprietary AI/digital modernization platform for government customers
2. **International expansion** — Australia, UK, Germany defense IT
3. **Advanced capabilities** — hypersonics, autonomous systems, directed energy (via Dynetics)
4. **Margin improvement** — targeting 10%+ operating margins over time from ~7% today

## Recent Catalysts

---
source: coverage-next-full
ticker: LDOS
step: "12"
title: Catalysts — Near-Term & Long-Term + Bull/Bear Cases
created: 2026-05-29
---

### Step 12 — Catalysts

#### Near-Term Catalysts (0-12 Months)

##### 1. FY2025 Full-Year Appropriations Resolution
If Congress passes a full FY2025 defense appropriations bill (rather than remaining under a CR), Leidos would see:
- Accelerated new program awards (~$200-300M in pulled-forward revenue)
- Release of funded backlog on programs that have been pending
- Management raised guidance by $200-300M in prior years following appropriations clarity

**Probability**: Medium (50-60%). Political dynamics suggest possible resolution by Q3 CY2025.

##### 2. VA EHRM Program Stabilization
If VA EHRM achieves successful go-lives at new facilities without additional patient safety incidents, the program could:
- Convert from margin drag to margin neutral
- Enable fee recovery on deferred performance awards
- Allow expansion to remaining VA sites (potential 20-30% Health segment revenue upside)

**Estimated margin impact**: 50-75bps Health segment margin improvement → ~20bps overall company improvement.

##### 3. Dynetics Hypersonics Contract Award
Leidos/Dynetics's HAWC (Hypersonic Air-breathing Weapon Concept) program has shown successful test results. A major production contract award could add $100-500M+ in incremental Defense Solutions revenue and carry above-average margins (advanced technology programs typically 10-12% margins).

**Probability**: Medium-High (given DoD's stated hypersonics investment priority).

##### 4. DISA Re-compete Win
The DISA SITE II contract re-compete is a major near-term event. An incumbent win would remove re-compete uncertainty from the bull thesis and reaffirm Leidos's classified IT capabilities. A loss would be a 10-15% earnings headwind.

##### 5. Share Repurchase Acceleration
As leverage approaches the 2.0-2.5x target, management has signaled willingness to accelerate buybacks. At current FCF of $1.1B and declining debt service requirements, buybacks of $600-700M/year are increasingly feasible — equivalent to ~4% annual share reduction.

#### Long-Term Catalysts (1-5 Years)

##### 6. ODIN Platform Adoption
If ODIN achieves meaningful adoption across DoD agencies (management suggests $1-2B+ platform revenue opportunity), it would:
- Transform Leidos's revenue mix toward higher-margin software-enabled services
- Expand operating margins from ~8% toward 12-14% (platform economics vs. services economics)
- Justify a premium valuation re-rating vs. pure-play services peers

##### 7. International Expansion
UK Defence and Australian Defence IT programs are growing markets. Leidos has established in-country presence in both. International revenue growth from 7% to 15% of total revenue would add ~$1.2B in incremental revenue with potentially higher margins (fewer classified pricing restrictions, broader scope of services).

##### 8. AI Integration in Defense — Market Expansion
The DoD's CDAO (Chief Digital and AI Office) is scaling AI adoption across warfighting domains. As the largest defense IT integrator, Leidos is positioned to be the implementation partner for AI/ML deployments at scale. This represents a new, additive demand layer rather than displacement of existing services.

##### 9. Intangibles Amortization Roll-Off
By FY2027-2028, the IS&GS acquisition intangibles will be ~$0-200M (vs. ~$1.3B net today). Annual amortization charge declines from ~$200M to ~$50M, causing GAAP EPS to converge toward non-GAAP EPS — potentially triggering significant institutional buying from value/blend managers who screen on GAAP metrics.

##### 10. Defense Budget Tailwind
If Congress passes a defense budget with real growth >3% annually (possible given peer competition with China), Leidos's addressable market grows proportionally. Historical correlation: LDOS organic revenue growth ≈ DoD IT budget growth + 1-2ppts of market share gain.

---

#### Bull Case

- **ODIN platform achieves breakout adoption** across 3+ major DoD agencies within 2 years, driving operating margins from 8% toward 11-12% and justifying a re-rating to 18-20x earnings (from current ~15x) — implying 40-60% upside to fair value.
- **Hypersonics + counter-UAS defense spending surge** following escalation in any major geopolitical theater (Taiwan, Middle East), driving Defense Solutions to 10%+ organic growth for 3+ consecutive years and book-to-bill sustained above 1.3x.
- **Intangibles amortization roll-off triggers GAAP EPS inflection** in FY2027-2028, causing GAAP EPS to jump 30-40% without any underlying business change — unlocking institutional demand from GAAP-screened value investors and driving multiple expansion.

#### Bear Case

- **DOGE civilian agency cuts + CR impact** causes Civil segment revenue to decline 10-15% through contract cancellations, while delayed DoD appropriations push Defense Solutions award timing to the right — leading to FY2025 revenue miss and guidance cut of $500M+.
- **VA EHRM contract termination or major penalty** forces Health segment into operating losses for 2+ years, impairs Leidos's past performance record, and reduces the probability of winning future Health IT contracts — creating a $300-400M structural revenue hole.
- **DISA SITE II re-compete loss** to Booz Allen or SAIC eliminates $500M+/year in high-margin classified revenue, reduces funded backlog by ~10%, and triggers EPS estimate reductions of 15-20% — driving the stock below $100 in a risk-off scenario.

## Full Investment Thesis (Premium)

The full research tier adds these thesis-critical dimensions:

- Moat Analysis — durable competitive advantages, switching costs, network effects
- Investment Thesis — variant perception, what has to be true, why market may be wrong
- Bull / Base / Bear Scenarios — probability weights, catalysts, price targets
- Risk Register — macro, competitive, execution, regulatory risks with materiality ratings
- Management Quality — capital allocation track record, incentive alignment
- DCF Valuation — 10-year model with sensitivity matrix

**API endpoint:** GET /api/v1/research/LDOS/memo

## Navigation

- Overview: /stocks/LDOS
- Financials: /stocks/LDOS/financials
- Thesis (this page): /stocks/LDOS/thesis
- Investment Memo: /stocks/LDOS/memo
- Coverage universe: /stocks